| Original language | English |
|---|---|
| Pages (from-to) | 349 |
| Number of pages | 1 |
| Journal | The British Journal of Psychiatry |
| Volume | 225 |
| Issue number | 2 |
| DOIs |
|
| Publication status | Published - 1 Aug 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research output
- 1 Citations
- 1 Article
-
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
Loo, C., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P., Glue, P., Sarma, S., Galvez-Ortiz, V., Hadzi-Pavlovic, D., Alonzo, A., Dong, V., Martin, D., Nikolin, S., Mitchell, P. B., Berk, M., Carter, G., Hackett, M., Leyden, J. & Hood, S. & 18 others, , Dec 2023, In: The British Journal of Psychiatry. 223, 6, p. 533-541 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access55 Link opens in a new tab Citations (Scopus)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver